LongTVTXJun 2026
Travere Therapeutics, Inc.
Travere Therapeutics specialises in treatments for rare kidney and metabolic disorders. Its foundational drug was recently approved for an additional kidney disease, expanding…
TVTX
Which hedge funds are long TVTX?
2 published ideas on Travere Therapeutics, Inc. across 1 fund — 2 long and 0 short.
Each entry below comes from a hedge fund's own investor letter, not a 13F filing, so it carries the reasoning behind the position on Travere Therapeutics, Inc.: the full thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Funds with a position view
Long theses
LongTVTXJun 2026
Travere Therapeutics, Inc.
abrdn initiated Travere Therapeutics, which focuses on rare kidney and metabolic disorders. A foundational drug recently received approval for an additional kidney disease…